UFC women’s flyweight Jennifer Maia has accepted a six-month suspension from USADA due to a positive drug test that resulted from a contaminated supplement.
The Las Vegas-based promotion released a statement on the situation on Tuesday. In on out-of-competition test conducted on Aug. 16, Maia tested positive for multiple banned substances — furosemide, hydrochlorothiazide, chlorothiazide, and the thiazide metabolite 4-amino-6-chloro-1,3-benzenedisulfonamide (ACB) — all of which fall into the category of diuretics and masking agents.
“During an investigation into the circumstances of her case, opened and sealed containers of a dietary supplement she was using at the time of the August 16, 2018 sample collection, and that she declared on her doping control form, were sent to the WADA-accredited laboratory in Brazil for analysis,” the statement read.